Citation Impact
Citing Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Influence of Statins on Influenza Vaccine Response in Elderly Individuals
2015
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
2023 StandoutNobel
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Prevention of otitis media: Now a reality?
2009
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children
2009
Current Challenges in Vaccinology
2020
Whither vaccines?
2017
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
2013
SARS-CoV-2 vaccines in development
2020 StandoutNature
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
2016
10-valent pneumococcal nontypeableHaemophilus influenzaePD conjugate vaccine: Synflorix™
2009
Prevention and Control of Seasonal Influenza with Vaccines
2016
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses
2017
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Inflammatory responses to influenza vaccination at the extremes of age
2017
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Works of Nancy Bermal being referenced
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
2014
Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines
2009
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
2011
Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
2009
The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
2009
IMMUNOGENICITY AND SAFETY OF A VARICELLA VACCINE (OKAVAX™) AND A TRIVALENT MEASLES, MUMPS, AND RUBELLA VACCINE (TRIMOVAX™) ADMINISTERED CONCOMITANTLY IN HEALTHY FILIPINO CHILDREN 12–24 MONTHS OLD
2004